In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Multiplex Detection Immunoassays
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Disease Testing Application, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.5 Billion ... Read More
-
Nucleic Acid Labeling
... by 2030, growing at a CAGR of 7.5% over the analysis period 2023-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 ... Read More
-
Oxidative Stress Assays
... by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. ELISA Technology, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$673.6 Million by ... Read More
-
Coagulation / Hemostasis Analyzers
... reach US$5.0 Billion by 2030, growing at a CAGR of 3.0% over the analysis period 2023-2030. Clinical Laboratory Analyzers, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and ... Read More
-
Testing and Analysis Services
... 2030, growing at a CAGR of 5.6% over the analysis period 2023-2030. Elemental Analysis, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.4 Billion by the ... Read More
-
Veterinary Hematology Analyzers
... at a CAGR of 5.3% over the analysis period 2023-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.2 Billion by the end ... Read More
-
Rapid Medical Diagnostic Kits
... 2030, growing at a CAGR of 3.6% over the analysis period 2023-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$10.7 ... Read More
-
Coagulation Factor Concentrates
... at a CAGR of 7.1% over the analysis period 2023-2030. Hospitals & Clinics End-Use, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$8.8 Billion by the ... Read More
-
Liver Cancer Diagnostics
... at a CAGR of 7.3% over the analysis period 2023-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$9.8 Billion by the end of ... Read More
-
Cell Analysis
... CAGR of 5.5% over the analysis period 2023-2030. Flow Cytometry Products, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$10.3 Billion by the end of the ... Read More
-
The Global Microfluidics Market 2025-2035
... to revolutionize traditional approaches to diagnostics, drug development, and process control. Medical applications currently dominate market share, with point-of-care diagnostics and pharmaceutical research leading growth, while industrial applications in environmental monitoring, food safety, and process ... Read More
-
Glucose Biosensors
... at a CAGR of 2.1% over the analysis period 2023-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 1.8% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Nucleic Acid Isolation and Purification
... is expected to reach US$12.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Nucleic Acid Isolation and Purification Kits, one of the segments analyzed in the report, is expected ... Read More
-
Thyroid Function Tests
... by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. TSH Tests, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.2 Billion by ... Read More
-
Point-of-Care Diagnostics: Technologies and Global Markets
... and market trends, including projections through 2029 and an analysis of key players. This report covers the entire industry, including hardware (devices, equipment, consumables), software, and analytics. The market is analyzed by test type, including ... Read More
-
Antithrombin
... of 5.2% over the analysis period 2023-2030. Therapeutics Application, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$847.5 Million by the end of the analysis period. ... Read More
-
Coagulation Testing
... at a CAGR of 4.7% over the analysis period 2023-2030. Coagulation Testing Consumables, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the end ... Read More
-
Histology and Cytology
... by 2030, growing at a CAGR of 14.4% over the analysis period 2023-2030. Cytology, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$50.6 Billion by the ... Read More
-
Hemoglobin Testing
... at a CAGR of 5.6% over the analysis period 2023-2030. Reagents & Consumables Component, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$3.0 Billion by the ... Read More
-
Oncology Molecular Diagnostics
... by 2030, growing at a CAGR of 11.1% over the analysis period 2023-2030. Breast Cancer, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by ... Read More
-
Therapeutic Plasma Exchange
... by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Neurological Disorders Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$789.6 Million ... Read More
-
Umbilical Cord Blood Banking
... 2030, growing at a CAGR of 10.1% over the analysis period 2023-2030. Public Cord Blood Banks, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$4.3 Billion ... Read More
-
Veterinary Molecular Diagnostics
... at a CAGR of 7.4% over the analysis period 2023-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$342.8 Million by the end ... Read More
-
Immunohematology Analyzers and Reagents
... reach US$3.3 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Immunohematology Reagents, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach ... Read More
-
In Vitro Toxicology Testing
... reach US$26.0 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2023-2030. Cell Culture In Vitro Toxicology Testing, one of the segments analyzed in the report, is expected to record a ... Read More
Research Assistance
